CME
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
November 15, 2022
Host: Benjamin Levy, MD Guest: Rebecca Heist, MD, MPH Guest: Peter Bela Illei, MD Antibody-drug conjugates (ADCs) have promising clinical data in the treatment of advanced non-small cell lung cancer. Listen in as Drs. Benjamin Levy, Rebecca Heist
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!